Table of Content

1 Ganirelix Market Overview
1.1 Product Overview and Scope of Ganirelix
1.2 Ganirelix Segment by Type
1.2.1 Global Ganirelix Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Patent
1.2.3 Generic
1.3 Ganirelix Segment by Application
1.3.1 Ganirelix Sales Comparison by Application: (2021-2027)
1.3.2 Polycystic Ovaries Syndrome
1.3.3 Ovarian Stimulation
1.3.4 Orthostatic Intolerance
1.3.5 Controlled Ovarian Stimulation
1.3.6 Infertility
1.4 Global Ganirelix Market Size Estimates and Forecasts
1.4.1 Global Ganirelix Revenue 2016-2027
1.4.2 Global Ganirelix Sales 2016-2027
1.4.3 Ganirelix Market Size by Region: 2016 Versus 2021 Versus 2027

2 Ganirelix Market Competition by Manufacturers
2.1 Global Ganirelix Sales Market Share by Manufacturers (2016-2021)
2.2 Global Ganirelix Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Ganirelix Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Ganirelix Manufacturing Sites, Area Served, Product Type
2.5 Ganirelix Market Competitive Situation and Trends
2.5.1 Ganirelix Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Ganirelix Players Market Share by Revenue
2.5.3 Global Ganirelix Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Ganirelix Retrospective Market Scenario by Region
3.1 Global Ganirelix Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Ganirelix Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Ganirelix Market Facts & Figures by Country
3.3.1 North America Ganirelix Sales by Country
3.3.2 North America Ganirelix Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Ganirelix Market Facts & Figures by Country
3.4.1 Europe Ganirelix Sales by Country
3.4.2 Europe Ganirelix Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Ganirelix Market Facts & Figures by Region
3.5.1 Asia Pacific Ganirelix Sales by Region
3.5.2 Asia Pacific Ganirelix Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Ganirelix Market Facts & Figures by Country
3.6.1 Latin America Ganirelix Sales by Country
3.6.2 Latin America Ganirelix Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Ganirelix Market Facts & Figures by Country
3.7.1 Middle East and Africa Ganirelix Sales by Country
3.7.2 Middle East and Africa Ganirelix Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Ganirelix Historic Market Analysis by Type
4.1 Global Ganirelix Sales Market Share by Type (2016-2021)
4.2 Global Ganirelix Revenue Market Share by Type (2016-2021)
4.3 Global Ganirelix Price by Type (2016-2021)

5 Global Ganirelix Historic Market Analysis by Application
5.1 Global Ganirelix Sales Market Share by Application (2016-2021)
5.2 Global Ganirelix Revenue Market Share by Application (2016-2021)
5.3 Global Ganirelix Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Organon
6.1.1 Organon Corporation Information
6.1.2 Organon Description and Business Overview
6.1.3 Organon Ganirelix Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Organon Product Portfolio
6.1.5 Organon Recent Developments/Updates
6.2 Sun Pharm
6.2.1 Sun Pharm Corporation Information
6.2.2 Sun Pharm Description and Business Overview
6.2.3 Sun Pharm Ganirelix Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Sun Pharm Product Portfolio
6.2.5 Sun Pharm Recent Developments/Updates
6.3 Merck Sharp and Dohme (MSD)
6.3.1 Merck Sharp and Dohme (MSD) Corporation Information
6.3.2 Merck Sharp and Dohme (MSD) Description and Business Overview
6.3.3 Merck Sharp and Dohme (MSD) Ganirelix Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merck Sharp and Dohme (MSD) Product Portfolio
6.3.5 Merck Sharp and Dohme (MSD) Recent Developments/Updates
6.4 Ferring Pharmaceuticals
6.4.1 Ferring Pharmaceuticals Corporation Information
6.4.2 Ferring Pharmaceuticals Description and Business Overview
6.4.3 Ferring Pharmaceuticals Ganirelix Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Ferring Pharmaceuticals Product Portfolio
6.4.5 Ferring Pharmaceuticals Recent Developments/Updates
6.5 Ambinter
6.5.1 Ambinter Corporation Information
6.5.2 Ambinter Description and Business Overview
6.5.3 Ambinter Ganirelix Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Ambinter Product Portfolio
6.5.5 Ambinter Recent Developments/Updates
6.6 BLD Pharm
6.6.1 BLD Pharm Corporation Information
6.6.2 BLD Pharm Description and Business Overview
6.6.3 BLD Pharm Ganirelix Sales, Revenue and Gross Margin (2016-2021)
6.6.4 BLD Pharm Product Portfolio
6.6.5 BLD Pharm Recent Developments/Updates
6.7 Chemenu
6.6.1 Chemenu Corporation Information
6.6.2 Chemenu Description and Business Overview
6.6.3 Chemenu Ganirelix Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Chemenu Product Portfolio
6.7.5 Chemenu Recent Developments/Updates

7 Ganirelix Manufacturing Cost Analysis
7.1 Ganirelix Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Ganirelix
7.4 Ganirelix Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Ganirelix Distributors List
8.3 Ganirelix Customers

9 Ganirelix Market Dynamics
9.1 Ganirelix Industry Trends
9.2 Ganirelix Growth Drivers
9.3 Ganirelix Market Challenges
9.4 Ganirelix Market Restraints

10 Global Market Forecast
10.1 Ganirelix Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Ganirelix by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Ganirelix by Type (2022-2027)
10.2 Ganirelix Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Ganirelix by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Ganirelix by Application (2022-2027)
10.3 Ganirelix Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Ganirelix by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Ganirelix by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Ganirelix Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Ganirelix Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Ganirelix Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Ganirelix Covered in This Study
Table 5. Global Ganirelix Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Ganirelix Sales Share by Manufacturers (2016-2021)
Table 7. Global Ganirelix Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Ganirelix Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Ganirelix Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Ganirelix Manufacturing Sites and Area Served
Table 11. Manufacturers Ganirelix Product Type
Table 12. Global Ganirelix Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Ganirelix by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ganirelix as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Ganirelix Sales by Region (2016-2021) & (K Units)
Table 16. Global Ganirelix Sales Market Share by Region (2016-2021)
Table 17. Global Ganirelix Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Ganirelix Sales by Country (2016-2021) & (K Units)
Table 19. North America Ganirelix Sales Market Share by Country (2016-2021)
Table 20. North America Ganirelix Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Ganirelix Revenue Market Share by Country (2016-2021)
Table 22. Europe Ganirelix Sales by Country (2016-2021) & (K Units)
Table 23. Europe Ganirelix Sales Market Share by Country (2016-2021)
Table 24. Europe Ganirelix Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Ganirelix Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Ganirelix Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Ganirelix Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Ganirelix Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Ganirelix Revenue Market Share by Region (2016-2021)
Table 30. Latin America Ganirelix Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Ganirelix Sales Market Share by Country (2016-2021)
Table 32. Latin America Ganirelix Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Ganirelix Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Ganirelix Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Ganirelix Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Ganirelix Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Ganirelix Revenue Market Share by Country (2016-2021)
Table 38. Global Ganirelix Sales (K Units) by Type (2016-2021)
Table 39. Global Ganirelix Sales Market Share by Type (2016-2021)
Table 40. Global Ganirelix Revenue (Million US$) by Type (2016-2021)
Table 41. Global Ganirelix Revenue Share by Type (2016-2021)
Table 42. Global Ganirelix Price (US$/Unit) by Type (2016-2021)
Table 43. Global Ganirelix Sales (K Units) by Application (2016-2021)
Table 44. Global Ganirelix Sales Market Share by Application (2016-2021)
Table 45. Global Ganirelix Revenue (Million US$) by Application (2016-2021)
Table 46. Global Ganirelix Revenue Share by Application (2016-2021)
Table 47. Global Ganirelix Price (US$/Unit) by Application (2016-2021)
Table 48. Organon Corporation Information
Table 49. Organon Description and Business Overview
Table 50. Organon Ganirelix Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Organon Ganirelix Product
Table 52. Organon Recent Developments/Updates
Table 53. Sun Pharm Corporation Information
Table 54. Sun Pharm Description and Business Overview
Table 55. Sun Pharm Ganirelix Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Sun Pharm Ganirelix Product
Table 57. Sun Pharm Recent Developments/Updates
Table 58. Merck Sharp and Dohme (MSD) Corporation Information
Table 59. Merck Sharp and Dohme (MSD) Description and Business Overview
Table 60. Merck Sharp and Dohme (MSD) Ganirelix Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Merck Sharp and Dohme (MSD) Ganirelix Product
Table 62. Merck Sharp and Dohme (MSD) Recent Developments/Updates
Table 63. Ferring Pharmaceuticals Corporation Information
Table 64. Ferring Pharmaceuticals Description and Business Overview
Table 65. Ferring Pharmaceuticals Ganirelix Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Ferring Pharmaceuticals Ganirelix Product
Table 67. Ferring Pharmaceuticals Recent Developments/Updates
Table 68. Ambinter Corporation Information
Table 69. Ambinter Description and Business Overview
Table 70. Ambinter Ganirelix Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Ambinter Ganirelix Product
Table 72. Ambinter Recent Developments/Updates
Table 73. BLD Pharm Corporation Information
Table 74. BLD Pharm Description and Business Overview
Table 75. BLD Pharm Ganirelix Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. BLD Pharm Ganirelix Product
Table 77. BLD Pharm Recent Developments/Updates
Table 78. Chemenu Corporation Information
Table 79. Chemenu Description and Business Overview
Table 80. Chemenu Ganirelix Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Chemenu Ganirelix Product
Table 82. Chemenu Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Ganirelix Distributors List
Table 86. Ganirelix Customers List
Table 87. Ganirelix Market Trends
Table 88. Ganirelix Growth Drivers
Table 89. Ganirelix Market Restraints
Table 90. Global Ganirelix Sales Forecast by Type (2022-2027) & (K Units)
Table 91. Global Ganirelix Sales Market Share Forecast by Type (2022-2027)
Table 92. Global Ganirelix Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 93. Global Ganirelix Revenue Market Share Forecast by Type (2022-2027)
Table 94. Global Ganirelix Sales Forecast by Application (2022-2027) & (K Units)
Table 95. Global Ganirelix Sales Market Share Forecast by Application (2022-2027)
Table 96. Global Ganirelix Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 97. Global Ganirelix Revenue Market Share Forecast by Application (2022-2027)
Table 98. Global Ganirelix Sales Forecast by Region (2022-2027) & (K Units)
Table 99. Global Ganirelix Sales Market Share Forecast by Region (2022-2027)
Table 100. Global Ganirelix Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 101. Global Ganirelix Revenue Market Share Forecast by Region (2022-2027)
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Ganirelix
Figure 2. Global Ganirelix Market Share by Type in 2020 & 2027
Figure 3. Patent Product Picture
Figure 4. Generic Product Picture
Figure 5. Global Ganirelix Market Share by Application in 2020 & 2027
Figure 6. Polycystic Ovaries Syndrome
Figure 7. Ovarian Stimulation
Figure 8. Orthostatic Intolerance
Figure 9. Controlled Ovarian Stimulation
Figure 10. Infertility
Figure 11. Global Ganirelix Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Ganirelix Market Size 2016-2027 (US$ Million)
Figure 13. Global Ganirelix Sales 2016-2027 (K Units)
Figure 14. Global Ganirelix Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Ganirelix Sales Share by Manufacturers in 2020
Figure 16. Global Ganirelix Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Ganirelix Players: Market Share by Revenue in 2020
Figure 18. Ganirelix Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Ganirelix Sales Market Share by Region (2016-2021)
Figure 20. Global Ganirelix Sales Market Share by Region in 2020
Figure 21. Global Ganirelix Revenue Market Share by Region (2016-2021)
Figure 22. Global Ganirelix Revenue Market Share by Region in 2020
Figure 23. U.S. Ganirelix Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Ganirelix Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Ganirelix Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Ganirelix Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Ganirelix Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Ganirelix Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Ganirelix Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Ganirelix Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Ganirelix Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Ganirelix Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Ganirelix Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Ganirelix Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Ganirelix Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Ganirelix Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Ganirelix Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Ganirelix Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Ganirelix Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Ganirelix Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Ganirelix Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Ganirelix Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Ganirelix Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Ganirelix Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Ganirelix Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. UAE Ganirelix Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Ganirelix by Type (2016-2021)
Figure 48. Sales Market Share of Ganirelix by Application (2016-2021)
Figure 49. Sales Market Share of Ganirelix by Application in 2020
Figure 50. Revenue Share of Ganirelix by Application (2016-2021)
Figure 51. Revenue Share of Ganirelix by Application in 2020
Figure 52. Manufacturing Cost Structure of Ganirelix
Figure 53. Manufacturing Process Analysis of Ganirelix
Figure 54. Ganirelix Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed